Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Cartesian Therapeutics (RNAC) Preferred Shares Issued (2023 - 2024)

Cartesian Therapeutics (RNAC) has disclosed Preferred Shares Issued for 2 consecutive years, with $40.0 million as the latest value for Q1 2024.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $40.0 million in Q1 2024 year-over-year; TTM through Dec 2024 was $40.0 million, a 97.53% increase, with the full-year FY2024 number at $40.0 million, up 97.53% from a year prior.
  • Preferred Shares Issued was $40.0 million for Q1 2024 at Cartesian Therapeutics, up from $20.2 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $40.0 million in Q1 2024 to a low of $20.2 million in Q4 2023.